Static Chart Abbott Laboratories

Stocks

Real-time Estimate Cboe BZX 16:45:13 26/10/2026 GMT			5-day change	1st Jan Change
104.35 ^USD	+0.63%		+0.70%	-16.36%

01:55pm	Abbott Laboratories Launches Oncodetect Molecular Residual Disease Test	MT
10-23	Abbott Presents New Esmo Data Showing 30-Percent Absolute Improvement in Sensitivity with the Whole-Genome Sequencing Oncodetect Test in Colorectal Cancer	CI

Duration

Period